Baseline Characteristics of Individuals with Paroxysmal Nocturnal Hemoglobinuria in an App-Based Home-Reported Outcomes Study to Evaluate Disease Burden

Poster Presentation
© 2024 American Society of Hematology. All rights reserved.
Meeting: 2024 ASH® Annual Meeting
Indication: Paroxysmal Nocturnal Hemoglobinuria (PNH)
Presenter: David Dingli, MD, PhD
Affiliation: Division of Hematology, Mayo Clinic, Rochester, MN
Presentation Date: December 7, 2024
Abstract Number: 2327
Session: Session: 905. Outcomes Research: Non-Malignant Conditions Excluding Hemoglobinopathies: Poster I
Related content: Paroxysmal Nocturnal Hemoglobinuria (PNH)
Poster Presentation
Abstract Number: 5012
Presenter: Shreyans Gandhi, MD, MBBS, DNB, FRCPath, MPhil, MRCP
Indication: Paroxysmal Nocturnal Hemoglobinuria (PNH)
Date Presented: December 9, 2024

To access this content please accept the following declarations.

This content was selected by and is provided to you upon your unsolicited request courtesy of Novartis with permission of ASH®.